nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acenocoumarol
|
|
|
2011 |
1334 |
1 |
p. 7 |
artikel |
2 |
Adalimumab
|
|
|
2011 |
1334 |
1 |
p. 7-8 |
artikel |
3 |
Adalimumab
|
|
|
2011 |
1334 |
1 |
p. 7 |
artikel |
4 |
Alemtuzumab
|
|
|
2011 |
1334 |
1 |
p. 8 |
artikel |
5 |
Allopurinol
|
|
|
2011 |
1334 |
1 |
p. 8 |
artikel |
6 |
Aminocaproic acid
|
|
|
2011 |
1334 |
1 |
p. 8 |
artikel |
7 |
Anagrelide/hydroxycarbamide
|
|
|
2011 |
1334 |
1 |
p. 8 |
artikel |
8 |
Analgesics
|
|
|
2011 |
1334 |
1 |
p. 9 |
artikel |
9 |
Antibacterials/immunosuppressants/voriconazole
|
|
|
2011 |
1334 |
1 |
p. 9 |
artikel |
10 |
Antibacterials/sulfasalazine
|
|
|
2011 |
1334 |
1 |
p. 10 |
artikel |
11 |
Antidepressants
|
|
|
2011 |
1334 |
1 |
p. 10 |
artikel |
12 |
Antifungals/bortezomib/dexamethasone
|
|
|
2011 |
1334 |
1 |
p. 11 |
artikel |
13 |
Antineoplastics
|
|
|
2011 |
1334 |
1 |
p. 11 |
artikel |
14 |
Antineoplastics
|
|
|
2011 |
1334 |
1 |
p. 11 |
artikel |
15 |
Antiretrovirals/BCG vaccine
|
|
|
2011 |
1334 |
1 |
p. 11-12 |
artikel |
16 |
Applications to update labelling for Tysabri submitted
|
|
|
2011 |
1334 |
1 |
p. 2 |
artikel |
17 |
Asparaginase
|
|
|
2011 |
1334 |
1 |
p. 12 |
artikel |
18 |
Aspirin/phosphatidylcholine safer for the stomach?
|
|
|
2011 |
1334 |
1 |
p. 5 |
artikel |
19 |
A US nationwide recall of sodium bicarbonate injection, USP 7.5% and 8.4% 50ml single dose vials
|
|
|
2011 |
1334 |
1 |
p. 3 |
artikel |
20 |
Azathioprine/ciclosporin/prednisone
|
|
|
2011 |
1334 |
1 |
p. 12 |
artikel |
21 |
Azathioprine/tacrolimus
|
|
|
2011 |
1334 |
1 |
p. 12 |
artikel |
22 |
Baclofen
|
|
|
2011 |
1334 |
1 |
p. 12 |
artikel |
23 |
Bee venom
|
|
|
2011 |
1334 |
1 |
p. 13 |
artikel |
24 |
Benzathine benzylpenicillin/procaine benzylpenicillin
|
|
|
2011 |
1334 |
1 |
p. 13 |
artikel |
25 |
Bevacizumab
|
|
|
2011 |
1334 |
1 |
p. 13 |
artikel |
26 |
Bevacizumab
|
|
|
2011 |
1334 |
1 |
p. 13 |
artikel |
27 |
Bevacizumab/carmustine
|
|
|
2011 |
1334 |
1 |
p. 14 |
artikel |
28 |
Bladder AEs with retigabine mostly mild and reversible
|
|
|
2011 |
1334 |
1 |
p. 5 |
artikel |
29 |
Bortezomib
|
|
|
2011 |
1334 |
1 |
p. 14 |
artikel |
30 |
Calcium/colecalciferol/hydrochlorothiazide
|
|
|
2011 |
1334 |
1 |
p. 14 |
artikel |
31 |
Capecitabine
|
|
|
2011 |
1334 |
1 |
p. 15 |
artikel |
32 |
Capecitabine
|
|
|
2011 |
1334 |
1 |
p. 14 |
artikel |
33 |
Carbamazepine
|
|
|
2011 |
1334 |
1 |
p. 15 |
artikel |
34 |
Ceftriaxone/piperacillin/tazobactam
|
|
|
2011 |
1334 |
1 |
p. 15 |
artikel |
35 |
Cephalosporin/erythromycin/penicillin
|
|
|
2011 |
1334 |
1 |
p. 16 |
artikel |
36 |
Cetuximab
|
|
|
2011 |
1334 |
1 |
p. 16 |
artikel |
37 |
Cetuximab/panitumumab
|
|
|
2011 |
1334 |
1 |
p. 16 |
artikel |
38 |
Ciclosporin
|
|
|
2011 |
1334 |
1 |
p. 16 |
artikel |
39 |
Cisplatin/gemcitabine
|
|
|
2011 |
1334 |
1 |
p. 17 |
artikel |
40 |
Clomipramine/methylthioninium chloride interaction
|
|
|
2011 |
1334 |
1 |
p. 17 |
artikel |
41 |
Clozapine
|
|
|
2011 |
1334 |
1 |
p. 17-18 |
artikel |
42 |
Colistimethate sodium
|
|
|
2011 |
1334 |
1 |
p. 18 |
artikel |
43 |
Corticosteroids
|
|
|
2011 |
1334 |
1 |
p. 18 |
artikel |
44 |
Cumberland Pharmaceuticals is voluntarily recalling six lots of Acetadote (acetylcysteine)
|
|
|
2011 |
1334 |
1 |
p. 2 |
artikel |
45 |
Cytarabine
|
|
|
2011 |
1334 |
1 |
p. 18 |
artikel |
46 |
Dalteparin sodium overdose
|
|
|
2011 |
1334 |
1 |
p. 18 |
artikel |
47 |
Dapsone overdose
|
|
|
2011 |
1334 |
1 |
p. 19 |
artikel |
48 |
Dermatophagoides antigens overdose
|
|
|
2011 |
1334 |
1 |
p. 19 |
artikel |
49 |
Desvenlafaxine
|
|
|
2011 |
1334 |
1 |
p. 19 |
artikel |
50 |
Dexamethasone injection vials recalled in the US
|
|
|
2011 |
1334 |
1 |
p. 2 |
artikel |
51 |
Diltiazem/fentanyl interaction
|
|
|
2011 |
1334 |
1 |
p. 19 |
artikel |
52 |
Diltiazem/fentanyl/propofol interaction
|
|
|
2011 |
1334 |
1 |
p. 20 |
artikel |
53 |
Diphtheria-tetanus vaccine
|
|
|
2011 |
1334 |
1 |
p. 20 |
artikel |
54 |
Disulfiram
|
|
|
2011 |
1334 |
1 |
p. 20-21 |
artikel |
55 |
Docetaxel
|
|
|
2011 |
1334 |
1 |
p. 21 |
artikel |
56 |
Docetaxel/epirubicin
|
|
|
2011 |
1334 |
1 |
p. 21 |
artikel |
57 |
Dorzolamide/timolol
|
|
|
2011 |
1334 |
1 |
p. 21 |
artikel |
58 |
Dosulepin overdose
|
|
|
2011 |
1334 |
1 |
p. 21 |
artikel |
59 |
Doxycycline/ornidazole
|
|
|
2011 |
1334 |
1 |
p. 22 |
artikel |
60 |
Duloxetine
|
|
|
2011 |
1334 |
1 |
p. 22 |
artikel |
61 |
Enalapril
|
|
|
2011 |
1334 |
1 |
p. 22 |
artikel |
62 |
Enfuvirtide
|
|
|
2011 |
1334 |
1 |
p. 22 |
artikel |
63 |
Escitalopram
|
|
|
2011 |
1334 |
1 |
p. 23 |
artikel |
64 |
Etanercept
|
|
|
2011 |
1334 |
1 |
p. 23 |
artikel |
65 |
Everolimus
|
|
|
2011 |
1334 |
1 |
p. 24 |
artikel |
66 |
Everolimus
|
|
|
2011 |
1334 |
1 |
p. 23 |
artikel |
67 |
Everolimus
|
|
|
2011 |
1334 |
1 |
p. 24 |
artikel |
68 |
FDA reviews safety of somatropin
|
|
|
2011 |
1334 |
1 |
p. 2 |
artikel |
69 |
Flecainide
|
|
|
2011 |
1334 |
1 |
p. 24 |
artikel |
70 |
Fluconazole
|
|
|
2011 |
1334 |
1 |
p. 24 |
artikel |
71 |
Fluoroquinolones classified based on QT prolongation risk
|
|
|
2011 |
1334 |
1 |
p. 3 |
artikel |
72 |
Fluorouracil
|
|
|
2011 |
1334 |
1 |
p. 25 |
artikel |
73 |
Gemcitabine
|
|
|
2011 |
1334 |
1 |
p. 25 |
artikel |
74 |
Gene polymorphisms and oxaliplatin-induced neuropathy
|
|
|
2011 |
1334 |
1 |
p. 4 |
artikel |
75 |
Heparin
|
|
|
2011 |
1334 |
1 |
p. 25 |
artikel |
76 |
Hepatitis B vaccine
|
|
|
2011 |
1334 |
1 |
p. 26 |
artikel |
77 |
Hib-DTaP-poliovirus vaccine/pneumococcal 7-valent CRM197 vaccine conjugate
|
|
|
2011 |
1334 |
1 |
p. 26 |
artikel |
78 |
Ibuprofen/paracetamol
|
|
|
2011 |
1334 |
1 |
p. 26 |
artikel |
79 |
Immune globulin
|
|
|
2011 |
1334 |
1 |
p. 27 |
artikel |
80 |
Immunosuppressants
|
|
|
2011 |
1334 |
1 |
p. 27 |
artikel |
81 |
Incidence of AEs related to glucocorticoids high in GCA
|
|
|
2011 |
1334 |
1 |
p. 4 |
artikel |
82 |
Infertility therapies
|
|
|
2011 |
1334 |
1 |
p. 27 |
artikel |
83 |
Infliximab
|
|
|
2011 |
1334 |
1 |
p. 28 |
artikel |
84 |
Infliximab
|
|
|
2011 |
1334 |
1 |
p. 28 |
artikel |
85 |
Infliximab
|
|
|
2011 |
1334 |
1 |
p. 28 |
artikel |
86 |
Influenza A virus vaccine H1N1
|
|
|
2011 |
1334 |
1 |
p. 28-29 |
artikel |
87 |
Influenza A virus vaccine H1N1/influenza virus vaccine
|
|
|
|
1334 |
1 |
p. 29 |
artikel |
88 |
Influenza A virus vaccine H1N1/influenza virus vaccine
|
|
|
2011 |
1334 |
1 |
p. 29 |
artikel |
89 |
Interferon-β-1a
|
|
|
2011 |
1334 |
1 |
p. 29 |
artikel |
90 |
Interferon-β-1a/interferon-β-1b
|
|
|
2011 |
1334 |
1 |
p. 30 |
artikel |
91 |
Interferon-α-2a/interferon-α-2b
|
|
|
2011 |
1334 |
1 |
p. 29 |
artikel |
92 |
Interruption of cART leads to anaemia, other clinical events
|
|
|
2011 |
1334 |
1 |
p. 5 |
artikel |
93 |
Itraconazole
|
|
|
2011 |
1334 |
1 |
p. 30 |
artikel |
94 |
Ketamine abuse
|
|
|
2011 |
1334 |
1 |
p. 30 |
artikel |
95 |
Lamotrigine
|
|
|
2011 |
1334 |
1 |
p. 30 |
artikel |
96 |
Linezolid
|
|
|
2011 |
1334 |
1 |
p. 30-31 |
artikel |
97 |
Lisinopril
|
|
|
2011 |
1334 |
1 |
p. 31 |
artikel |
98 |
Meropenem
|
|
|
2011 |
1334 |
1 |
p. 31 |
artikel |
99 |
Meropenem
|
|
|
2011 |
1334 |
1 |
p. 31 |
artikel |
100 |
Metformin
|
|
|
2011 |
1334 |
1 |
p. 32 |
artikel |
101 |
Methadone overdose
|
|
|
2011 |
1334 |
1 |
p. 32 |
artikel |
102 |
Methotrexate
|
|
|
2011 |
1334 |
1 |
p. 32 |
artikel |
103 |
Methotrexate/cola interaction
|
|
|
2011 |
1334 |
1 |
p. 32 |
artikel |
104 |
Methyl aminolevulinate
|
|
|
2011 |
1334 |
1 |
p. 33 |
artikel |
105 |
Methylphenidate
|
|
|
2011 |
1334 |
1 |
p. 33 |
artikel |
106 |
Metoprolol
|
|
|
2011 |
1334 |
1 |
p. 33 |
artikel |
107 |
Mirtazapine
|
|
|
2011 |
1334 |
1 |
p. 33 |
artikel |
108 |
Mislabelling has prompted a US-wide voluntary recall of salbutamol [albuterol] unit dose vials.
|
|
|
2011 |
1334 |
1 |
p. 3 |
artikel |
109 |
MMR vax/autism study deemed fraudulent
|
|
|
2011 |
1334 |
1 |
p. 1 |
artikel |
110 |
Modafinil use not shown to exacerbate seizures
|
|
|
2011 |
1334 |
1 |
p. 6 |
artikel |
111 |
More muscle pain/weakness with raltegravir than darunavir
|
|
|
2011 |
1334 |
1 |
p. 6 |
artikel |
112 |
Morphine
|
|
|
2011 |
1334 |
1 |
p. 33 |
artikel |
113 |
Mycophenolic acid/mycophenolate mofetil
|
|
|
2011 |
1334 |
1 |
p. 34 |
artikel |
114 |
Neratinib once-daily and twice-daily dosages are comparable for onset of diarrhoea,
|
|
|
2011 |
1334 |
1 |
p. 4 |
artikel |
115 |
Nicorandil
|
|
|
2011 |
1334 |
1 |
p. 34 |
artikel |
116 |
Nicorandil
|
|
|
2011 |
1334 |
1 |
p. 34 |
artikel |
117 |
Nortriptyline/risperidone
|
|
|
2011 |
1334 |
1 |
p. 34 |
artikel |
118 |
Olanzapine
|
|
|
2011 |
1334 |
1 |
p. 35 |
artikel |
119 |
Omeprazole
|
|
|
2011 |
1334 |
1 |
p. 35 |
artikel |
120 |
Oxaliplatin
|
|
|
2011 |
1334 |
1 |
p. 35 |
artikel |
121 |
Paracetamol
|
|
|
2011 |
1334 |
1 |
p. 35-36 |
artikel |
122 |
Paracetamol
|
|
|
2011 |
1334 |
1 |
p. 36 |
artikel |
123 |
Paracetamol overdose
|
|
|
2011 |
1334 |
1 |
p. 36 |
artikel |
124 |
Peginterferon-α-2a/ribavirin
|
|
|
2011 |
1334 |
1 |
p. 36-37 |
artikel |
125 |
Phenobarbital/valproic acid
|
|
|
2011 |
1334 |
1 |
p. 37 |
artikel |
126 |
Phentermine
|
|
|
2011 |
1334 |
1 |
p. 37 |
artikel |
127 |
Phenytoin
|
|
|
2011 |
1334 |
1 |
p. 37 |
artikel |
128 |
Piperacillin/tazobactam
|
|
|
2011 |
1334 |
1 |
p. 38 |
artikel |
129 |
Piperacillin/tazobactam
|
|
|
2011 |
1334 |
1 |
p. 37-38 |
artikel |
130 |
Pivampicillin
|
|
|
2011 |
1334 |
1 |
p. 38 |
artikel |
131 |
Prednisone
|
|
|
2011 |
1334 |
1 |
p. 38 |
artikel |
132 |
Prednisone
|
|
|
2011 |
1334 |
1 |
p. 38 |
artikel |
133 |
Procainamide
|
|
|
2011 |
1334 |
1 |
p. 38 |
artikel |
134 |
Propafenone
|
|
|
2011 |
1334 |
1 |
p. 39 |
artikel |
135 |
Propranolol
|
|
|
2011 |
1334 |
1 |
p. 39 |
artikel |
136 |
Ranibizumab
|
|
|
2011 |
1334 |
1 |
p. 39 |
artikel |
137 |
Risperidone
|
|
|
2011 |
1334 |
1 |
p. 40 |
artikel |
138 |
Ritodrine
|
|
|
2011 |
1334 |
1 |
p. 40 |
artikel |
139 |
Ritonavir-boosted PIs + vinblastine ups neutropenia risk
|
|
|
2011 |
1334 |
1 |
p. 5 |
artikel |
140 |
Rituximab associated with “few” congenital abnormalities
|
|
|
2011 |
1334 |
1 |
p. 6 |
artikel |
141 |
RockHard Laboratories is conducting a voluntary nationwide recall of its dietary supplements,
|
|
|
2011 |
1334 |
1 |
p. 3 |
artikel |
142 |
Rotavirus vaccine
|
|
|
2011 |
1334 |
1 |
p. 40 |
artikel |
143 |
Sevoflurane
|
|
|
2011 |
1334 |
1 |
p. 40 |
artikel |
144 |
Streptokinase
|
|
|
2011 |
1334 |
1 |
p. 40 |
artikel |
145 |
Sunitinib
|
|
|
2011 |
1334 |
1 |
p. 41 |
artikel |
146 |
Sunitinib
|
|
|
2011 |
1334 |
1 |
p. 41 |
artikel |
147 |
Telmisartan/hydrochlorothiazide
|
|
|
2011 |
1334 |
1 |
p. 41 |
artikel |
148 |
Temozolomide
|
|
|
2011 |
1334 |
1 |
p. 42 |
artikel |
149 |
Temozolomide
|
|
|
2011 |
1334 |
1 |
p. 42 |
artikel |
150 |
Teucrium polium
|
|
|
2011 |
1334 |
1 |
p. 42-43 |
artikel |
151 |
Theophylline
|
|
|
2011 |
1334 |
1 |
p. 43 |
artikel |
152 |
The UK's MHRA says that “there is no indication of an excess risk of febrile convulsions in children following seasonal flu vaccination”.
|
|
|
2011 |
1334 |
1 |
p. 3 |
artikel |
153 |
The US Pharmacopeial Convention (USP) is proposing universal standards for prescription medication labels
|
|
|
2011 |
1334 |
1 |
p. 3 |
artikel |
154 |
Tigecycline
|
|
|
2011 |
1334 |
1 |
p. 43 |
artikel |
155 |
Tocilizumab
|
|
|
2011 |
1334 |
1 |
p. 43 |
artikel |
156 |
Topiramate
|
|
|
2011 |
1334 |
1 |
p. 43 |
artikel |
157 |
Triamcinolone
|
|
|
2011 |
1334 |
1 |
p. 44 |
artikel |
158 |
Trypan blue
|
|
|
2011 |
1334 |
1 |
p. 44 |
artikel |
159 |
Valproic acid
|
|
|
2011 |
1334 |
1 |
p. 44 |
artikel |
160 |
Venlafaxine
|
|
|
2011 |
1334 |
1 |
p. 45 |
artikel |
161 |
Vitamin B may be harmful in diabetic nephropathy
|
|
|
2011 |
1334 |
1 |
p. 4 |
artikel |
162 |
Voriconazole
|
|
|
2011 |
1334 |
1 |
p. 45 |
artikel |
163 |
Warfarin
|
|
|
2011 |
1334 |
1 |
p. 45 |
artikel |
164 |
Warfarin
|
|
|
2011 |
1334 |
1 |
p. 45 |
artikel |
165 |
Zinc sulfate
|
|
|
2011 |
1334 |
1 |
p. 46 |
artikel |
166 |
Zoledronic acid
|
|
|
2011 |
1334 |
1 |
p. 46 |
artikel |
167 |
Zoledronic acid
|
|
|
2011 |
1334 |
1 |
p. 46 |
artikel |
168 |
Zoledronic acid
|
|
|
2011 |
1334 |
1 |
p. 46 |
artikel |